<DOC>
	<DOCNO>NCT01209143</DOCNO>
	<brief_summary>This single-arm , multicenter , Phase Ib study design describe effect GDC-0449 pharmacokinetics rosiglitazone oral contraceptive patient advance solid tumor refractory treatment standard therapy exists .</brief_summary>
	<brief_title>A Study Pharmacokinetic Drug Interaction Study Hedgehog Pathway Inhibitor GDC-0449 Combination With Rosiglitazone Combined Oral Contraceptive Patients With Locally Advanced Metastatic Solid Tumors That Are Refractory Standard Therapy Whom No Standard Therapy Exists</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Histologic documentation incurable , locally advanced , metastatic solid malignancy fail respond least one prior regimen standard therapy Documented negative serum pregnancy test woman childbearing potential use two form contraception . Contraception must use patient enrol study 12 month patient discontinues study . For men female partner childbearing potential , agreement use latex condom advise female partner use additional method contraception study 3 month last dose GDC0449 . Agreement donate blood blood product study least 12 month last dose GDC0449 For male patient , agreement donate sperm study least 3 month last dose GDC0449 Adequate hematopoietic capacity Adequate renal function Adequate hepatic function At least 3 week since patient 's last chemotherapy , investigational agent , radiation therapy , major surgical procedure recovery pretreatment baseline stabilization treatmentrelated toxicity Active infection require intravenous ( IV ) antibiotic Clinically important history liver disease significantly impair hepatic function , include active viral hepatitis , current alcohol abuse , cirrhosis Any medical condition diagnosis would likely impair absorption orally administer drug Pregnant lactating Treatment exclude medication , include strong CYP450 inhibitor inducer , within 2 week study entry Male patient already receive rosiglitazone Male patient know contraindication rosiglitazone Female patient already receive oral contraception &lt; 14 day prior Day 1 Female patient know contraindication oral contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>